The first case report of polymerase proofreading-associated polyposis in POLD1 variant, c.1433G>A p.S478N, in Japan.

Polymerase proofreading-associated polyposis, caused by germline variants in the exonuclease domains of POLD1 and POLE, is a dominantly inherited rare condition characterized by oligo-adenomatous polyposis and increased risk of colorectal cancer, endometrial cancer and brain tumours. We report the first Japanese case of polymerase proofreading-associated polyposis carrying a POLD1 variant. The proband was a Japanese woman who had undergone resections of early colorectal carcinomas repeatedly and a hysterectomy with bilateral oophorectomy for endometrial cancer, all of which were diagnosed within 2 years after the first colectomy at 49 year old. Colonoscopic examinations demonstrated at least 14 non-cancerous polypoid lesions, some of which were histologically confirmed to be adenoma. Multigene panel sequencing identified a missense variant in POLD1 (c.1433G>A). Although her relatives did not undergo genetic testing, her father and paternal grandfather died of brain tumours at 53 and ~30 years of age, respectively.

[1]  大腸癌研究会.  Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication] , 2019, Journal of the anus, rectum and colon.

[2]  C. Boland,et al.  Novel candidates in early-onset familial colorectal cancer , 2019, Familial Cancer.

[3]  Y. Furukawa,et al.  Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient , 2019, Journal of Human Genetics.

[4]  Ian Tomlinson,et al.  A panoply of errors: polymerase proofreading domain mutations in cancer , 2016, Nature Reviews Cancer.

[5]  J. Vockley,et al.  Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas. , 2015, Gastroenterology.

[6]  A. Valencia,et al.  POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance , 2015, Genetics in Medicine.

[7]  Randall W Burt,et al.  ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes , 2015, The American Journal of Gastroenterology.

[8]  P. Broderick,et al.  Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Chris Sander,et al.  Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replication , 2014, Genome research.

[10]  C. Lázaro,et al.  New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis. , 2014, Human molecular genetics.

[11]  J. Church.  Polymerase proofreading-associated polyposis: a new, dominantly inherited syndrome of hereditary colorectal cancer predisposition. , 2014, Diseases of the colon and rectum.

[12]  I. Tomlinson,et al.  Replicative DNA polymerase mutations in cancer☆ , 2014, Current opinion in genetics & development.

[13]  Ian Tomlinson,et al.  Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers , 2013, The Journal of pathology.

[14]  I. Tomlinson,et al.  DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer , 2013, Human molecular genetics.

[15]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[16]  S. Pecorelli.  Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium , 2009 .

[17]  J. Zalcberg,et al.  Recent advances in the treatment of colorectal cancer. , 1992, Australian and New Zealand journal of medicine.

[18]  Ewout W Steyerberg,et al.  The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. , 2011, Gastroenterology.